JPS6261585B2 - - Google Patents
Info
- Publication number
- JPS6261585B2 JPS6261585B2 JP15004881A JP15004881A JPS6261585B2 JP S6261585 B2 JPS6261585 B2 JP S6261585B2 JP 15004881 A JP15004881 A JP 15004881A JP 15004881 A JP15004881 A JP 15004881A JP S6261585 B2 JPS6261585 B2 JP S6261585B2
- Authority
- JP
- Japan
- Prior art keywords
- hpg
- pes
- optically active
- hydroxyphenylglycine
- epimerization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000006345 epimerization reaction Methods 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 20
- LJCWONGJFPCTTL-UHFFFAOYSA-N 4-hydroxyphenylglycine Chemical compound OC(=O)C(N)C1=CC=C(O)C=C1 LJCWONGJFPCTTL-UHFFFAOYSA-N 0.000 claims description 16
- COFMBBYARPOGBA-UHFFFAOYSA-N 1-phenylethanesulfonic acid Chemical compound OS(=O)(=O)C(C)C1=CC=CC=C1 COFMBBYARPOGBA-UHFFFAOYSA-N 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 14
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 12
- 229930195729 fatty acid Natural products 0.000 claims description 12
- 239000000194 fatty acid Substances 0.000 claims description 12
- 150000004665 fatty acids Chemical class 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 150000003934 aromatic aldehydes Chemical class 0.000 claims description 4
- KKLMJYDGZSAIQX-UHFFFAOYSA-N 2-(n-hydroxyanilino)acetic acid Chemical compound OC(=O)CN(O)C1=CC=CC=C1 KKLMJYDGZSAIQX-UHFFFAOYSA-N 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 238000001640 fractional crystallisation Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229920003208 poly(ethylene sulfide) Polymers 0.000 description 64
- 229920006393 polyether sulfone Polymers 0.000 description 64
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- IAVPGZZRAJUOGE-UHFFFAOYSA-N [n'-(2-hydroxy-2-phenylethyl)carbamimidoyl]azanium;carbonate Chemical compound [O-]C([O-])=O.NC([NH3+])=NCC(O)C1=CC=CC=C1.NC([NH3+])=NCC(O)C1=CC=CC=C1 IAVPGZZRAJUOGE-UHFFFAOYSA-N 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 239000013078 crystal Substances 0.000 description 11
- 230000003287 optical effect Effects 0.000 description 11
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 10
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- -1 for example Chemical compound 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 150000003863 ammonium salts Chemical class 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 5
- 150000001299 aldehydes Chemical class 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- LJCWONGJFPCTTL-SSDOTTSWSA-N D-4-hydroxyphenylglycine Chemical compound [O-]C(=O)[C@H]([NH3+])C1=CC=C(O)C=C1 LJCWONGJFPCTTL-SSDOTTSWSA-N 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- CRRUGYDDEMGVDY-UHFFFAOYSA-N 1-bromoethylbenzene Chemical compound CC(Br)C1=CC=CC=C1 CRRUGYDDEMGVDY-UHFFFAOYSA-N 0.000 description 1
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 1
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-Phenylethanol Natural products OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
- CMWKITSNTDAEDT-UHFFFAOYSA-N 2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1C=O CMWKITSNTDAEDT-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- JVVXZOOGOGPDRZ-SLFFLAALSA-N [(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanamine Chemical compound NC[C@]1(C)CCC[C@]2(C)C3=CC=C(C(C)C)C=C3CC[C@H]21 JVVXZOOGOGPDRZ-SLFFLAALSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 230000020176 deacylation Effects 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は光学活性P−ヒドロキシフエニルグリ
シン塩の新規製法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel method for producing optically active P-hydroxyphenylglycine salts.
光学活性P−ヒドロキシフエニルグリシンは有
用な化合物であり、例えばD−P−ヒドロキシフ
エニルグリシンは半合成ペニシリンや半合成セフ
アロスポリンの原料化合物として重要であり、
又、L−P−ヒドロキシフエニルグリシンは虚血
性心臓疾患、心機能不全又は糖尿病などの治療に
用い得るものである(特開昭52−41432号)。 Optically active P-hydroxyphenylglycine is a useful compound, for example, D-P-hydroxyphenylglycine is important as a raw material compound for semi-synthetic penicillin and semi-synthetic cephalosporin.
Furthermore, LP-hydroxyphenylglycine can be used for the treatment of ischemic heart disease, cardiac dysfunction, diabetes, etc. (Japanese Patent Application Laid-open No. 41432/1983).
しかしながらP−ヒドロキシフエニルグリシン
は天然には存在せず合成によつてのみ得られる。
合成されたP−ヒドロキシフエニルグリシンは
DL体であるため、その光学活性体を得るには更
に光学分割が必要である。従来、P−ヒドロキシ
フエニルグリシンの化学的分割方法としては例え
ばDL−P−ヒドロキシフエニルグリシンをN−
ベンジルオキシカルボニル誘導体、N−クロロア
セチル誘導体、N−ベンゾイル誘導体に変換し、
これらをキニン、デヒドロアビエチルアミン、光
学活性α−フエネチルアミンなど分割する方法
(J.Chem.Soc.(c),1971,1920〜1922,;特開昭
49−56946号、特開昭50−69039号)が知られてい
る。しかしながら、これらの方法ではいずれも
DL−P−ヒドロキシフエニルグリシンを一旦ア
シル誘導体に変換しなければならない上、分割剤
も高価であり、また光学分割後脱アシル化の際ラ
セミ化を伴う危険性がある。又、DL−P−ヒド
ロキシフエニルグリシンをd−3−ブロムカンフ
アー−10−スルホン酸塩として分割する方法(特
開昭51−32541号)、d−3−ブロムカンフアー−
8−スルホン酸塩として分割する方法(特開昭55
−45069号)も知られているが、これらの方法も
分割後溶存するL−P−ヒドロキシフエニルグリ
シン塩が、そのままではラセミ化し得ないことか
ら、再利用のためのラセミ化に際しては一旦これ
を遊離アミノ酸に戻さねばならないという難点が
あつた。 However, P-hydroxyphenylglycine does not exist in nature and can only be obtained synthetically.
The synthesized P-hydroxyphenylglycine is
Since it is a DL form, further optical resolution is required to obtain its optically active form. Conventionally, as a chemical resolution method for P-hydroxyphenylglycine, for example, DL-P-hydroxyphenylglycine is converted into N-
Converted to benzyloxycarbonyl derivative, N-chloroacetyl derivative, N-benzoyl derivative,
A method of dividing these into quinine, dehydroabiethylamine, optically active α-phenethylamine, etc. (J.Chem.Soc.(c), 1971, 1920-1922,;
No. 49-56946, Japanese Patent Application Laid-open No. 50-69039) are known. However, all of these methods
DL-P-hydroxyphenylglycine must be converted into an acyl derivative once, the resolving agent is expensive, and there is a risk of racemization during deacylation after optical resolution. Also, a method for resolving DL-P-hydroxyphenylglycine as d-3-bromocamphor-10-sulfonate (Japanese Patent Application Laid-open No. 32541/1983), d-3-bromocamphor-10-sulfonate
8-Sulfonate method
-45069) is also known, but since the L-P-hydroxyphenylglycine salt dissolved in these methods cannot be racemized as it is, it is necessary to racemize it for reuse. The problem was that it had to be converted back to free amino acids.
かかる状況に鑑み本発明者らは鋭意研究を重ね
た結果、DL−P−ヒドロキシフエニルグリシン
と光学活性α−フエニルエタンスルホン酸とによ
つて形成される2種ジアステレオマーの易溶性ジ
アステレオマーがそのまま水又は脂肪酸中すみや
かにエピメリ化されること、またエピメリ化によ
り生ずる当該塩の難溶性ジアステレオマーはかか
る易溶性ジアステレオマーのエピメリ化条件下で
も晶出させ得ること、更にこの様にして晶出した
難溶性ジアステレオマーは上記エピメリ化条件下
でもエピメリ化されることなく安定な結晶として
存在することを見出した。 In view of this situation, the present inventors have conducted intensive research and found that two easily soluble diastereomers formed by DL-P-hydroxyphenylglycine and optically active α-phenylethanesulfonic acid have been developed. The fact that the stereomer is readily epimerized as it is in water or fatty acids, and that the poorly soluble diastereomer of the salt resulting from epimerization can be crystallized even under the epimerization conditions of such easily soluble diastereomer; It has been found that the poorly soluble diastereomer crystallized in this manner exists as stable crystals without being epimerized even under the above epimerization conditions.
本発明はこれらの新規知見にもとづき完成され
たものであつてヒドロキシフエニルグリシンと光
学活性α−フエニルエタンスルホン酸とによつて
形成される2種ジアステレオマーのうちその易溶
性ジアステレオマーのエピメリ化と難溶性ジアス
テレオマーの晶出とを行なわせることにより結果
としてかかる2種ジアステレオマーを選択的に難
溶性ジアステレオマーに転換させる方法である。 The present invention has been completed based on these new findings, and is an easily soluble diastereomer of two diastereomers formed by hydroxyphenylglycine and optically active α-phenylethanesulfonic acid. In this method, the two diastereomers are selectively converted into the poorly soluble diastereomer by epimerization of the diastereomer and crystallization of the poorly soluble diastereomer.
即ち、本発明によれば、光学活性P−ヒドロキ
シフエニルグリシン・光学活性α−フエニルエタ
ンスルホン酸塩はDL−P−ヒドロキシフエニル
グリシン・光学活性α−フエニルエタンスルホン
酸塩の2種ジアステレオマーのうちの易溶性ジア
ステレオマーをエピメリ化せしめ、晶出する難溶
性ジアステレオマーを採取することにより製する
ことができる。 That is, according to the present invention, optically active P-hydroxyphenylglycine/optically active α-phenylethanesulfonate is composed of two types: DL-P-hydroxyphenylglycine/optically active α-phenylethanesulfonate. It can be produced by epimerizing easily soluble diastereomers among the diastereomers and collecting the crystallized poorly soluble diastereomers.
本発明で使用するDL−P−ヒドロキシフエニ
ルグリシン(以下、DL−HPGと称する)はD体
とL体の等量混合物であつてもよく、又、一方の
光学活性体が過剰に含まれるものであつてもよ
い。かかるDL−HPGとしては例えば合成法によ
り得られるDL−HPGであつても良く、或いはL
−又はD−P−ヒドロキシフエニルグリシン(以
下、D−HPG又はL−HPGと称する)を過剰に
含むもの例えばDL−HPGからD−又はL−P−
ヒドロキシフエニルグリシンを公知方法で分離し
たあとに得られるものであつてもよい。これら
DL−HPGは遊離のものだけでなく塩酸塩、硫酸
塩の如き鉱酸塩、シユウ酸塩、スルホン酸塩の如
き有機酸塩であつても用いることができる。 DL-P-hydroxyphenylglycine (hereinafter referred to as DL-HPG) used in the present invention may be a mixture of equal amounts of D-form and L-form, or one optically active form may be contained in excess. It can be something. Such DL-HPG may be, for example, DL-HPG obtained by a synthetic method, or L
- or D-P-hydroxyphenylglycine (hereinafter referred to as D-HPG or L-HPG) in excess, for example, from DL-HPG to D- or L-P-
It may be obtained after separating hydroxyphenylglycine by a known method. these
DL-HPG can be used not only in its free form but also in the form of mineral acid salts such as hydrochloride and sulfate, and organic acid salts such as oxalate and sulfonate.
又、光学活性α−フエニルエタンスルホン酸
(以下、光学活性PESと称する)としては(±)−
α−フエニルエタンスルホン酸を光学分割して得
られる(+)−α−フエニルエタンスルホン酸
(以下、(+)−PESと称する)又は(−)−α−フ
エニルエタンスルホン酸(以下、(−)−PESと称
する)のいずれをも本発明の目的に用いることが
でき、更には遊離のものであつても、カリウム
塩、ナトリウム塩の如きアルカリ金属塩、カルシ
ウム塩、マグネシウム塩の如きアルカリ土類金属
塩又はアンモニウム塩であつても用いることがで
きる。これらの光学活性PESはDL−HPGに対し
約0.5モル比以上、とりわけ約0.8〜1.1モル比で使
用するのが適当である。 In addition, optically active α-phenylethanesulfonic acid (hereinafter referred to as optically active PES) is (±)-
(+)-α-phenylethanesulfonic acid (hereinafter referred to as (+)-PES) or (-)-α-phenylethanesulfonic acid (hereinafter referred to as (+)-PES) obtained by optical resolution of α-phenylethanesulfonic acid. , (-)-PES) can be used for the purpose of the present invention, and even in free form, alkali metal salts such as potassium salts and sodium salts, calcium salts, and magnesium salts can be used for the purpose of the present invention. Alkaline earth metal salts such as alkaline earth metal salts or ammonium salts can also be used. Suitably, these optically active PESs are used in a molar ratio of about 0.5 or more to DL-HPG, particularly about 0.8 to 1.1 molar ratio.
上記DL−HPGと光学活性PESとを反応させて
得られる塩は2種ジアステレオマーの混合物であ
るが、これら2種ジアステレオマーのうち易溶性
ジアステレオマーのエピメリ化条件及び難溶性ジ
アステレオマーの晶出条件は特に限定されない。
例えばエピメリ化は水の存在下に加熱するか、或
いは低級脂肪酸中、脂肪族もしくは芳香族アルデ
ヒドの共存下にかく拌することにより実施でき
る。又晶析は常温乃至加熱下のいずれであつても
よい。該易溶性ジアステレオマーのエピメリ化
は、該エピメリ化により生じた難溶性ジアステレ
オマーが晶出する条件下に行なうのが好ましい。 The salt obtained by reacting the above-mentioned DL-HPG and optically active PES is a mixture of two types of diastereomers. The conditions for crystallizing mer are not particularly limited.
For example, epimerization can be carried out by heating in the presence of water or stirring in a lower fatty acid in the presence of an aliphatic or aromatic aldehyde. Further, crystallization may be performed at room temperature or under heating. The epimerization of the easily soluble diastereomer is preferably carried out under conditions such that the poorly soluble diastereomer produced by the epimerization crystallizes.
上記において光学活性PESとして(+)−PES
を用いた場合、DL−HPG・光学活性PES塩はD
−HPG・(+)−PESとL−HPG・(+)−PESの
2種のジアステレオマーの混合物として得られる
が、これら2種のジアステレオマーは上記エピメ
リ化条件下ではD−HPG・(+)−PESが難溶性
ジアステレオマーとなり、L−HPG・(+)−
PESが易溶性ジアステレオマーとなる。 (+)-PES as optically active PES in the above
When using DL-HPG/optically active PES salt, D
-HPG・(+)-PES and L-HPG・(+)-PES are obtained as a mixture of two diastereomers, but under the above epimerization conditions, D-HPG・(+)-PES becomes a poorly soluble diastereomer, L-HPG・(+)-
PES becomes a readily soluble diastereomer.
一方、光学活性PESとして(−)−PESを用い
た場合にはL−HPG・(−)−PESが難溶性ジア
ステレオマーとなり、D−HPG・(−)−PESが
易溶性ジアステレオマーとなる。 On the other hand, when (-)-PES is used as the optically active PES, L-HPG/(-)-PES becomes a poorly soluble diastereomer, and D-HPG/(-)-PES becomes a readily soluble diastereomer. Become.
従つて、DL−HPG・光学活性PESは上記エピ
メリ化条件下に晶出させるに際しては、2種ジア
ステレオマーのうち難溶性ジアステレオマーたる
D−HPG・(+)−PES又はL−HPG・(−)−
PESが先ず晶出すると共に易溶性ジアステレオマ
ーたるD−HPG・(−)−PES又はL−HPG・
(+)−PESのエピメリ化が進行し、これにより生
じた難溶性ジアステレオマーが更に晶出する。し
かも一旦晶出した難溶性ジアステレオマーはエピ
メリ化をうけないため、エピメリ化と分別晶析を
実施すれば反応系中のDL−HPG・光学活性PES
は実質的にすべて難溶性ジアステレオマーたるD
−HPG・(+)−PES又はL−HPG・(−)−PES
として得ることができる。上記エピメリ化反応を
水の存在下、加熱して実施する場合はDL−HPG
と光学活性PESに少量の水を加えて加熱すればよ
く、反応は約80〜160℃、とりわけ約100〜150℃
で好適に進行する。 Therefore, when crystallizing DL-HPG/optically active PES under the above epimerization conditions, D-HPG/(+)-PES or L-HPG/ (−)−
PES first crystallizes out, and the easily soluble diastereomer D-HPG・(−)-PES or L-HPG・
Epimerization of (+)-PES progresses, and the resulting poorly soluble diastereomer further crystallizes. Moreover, once crystallized poorly soluble diastereomers do not undergo epimerization, if epimerization and fractional crystallization are performed, DL-HPG and optically active PES in the reaction system
are substantially all poorly soluble diastereomers D
−HPG・(+)−PES or L−HPG・(−)−PES
can be obtained as When the above epimerization reaction is carried out by heating in the presence of water, DL-HPG
All you have to do is add a small amount of water to optically active PES and heat it, and the reaction will occur at about 80-160℃, especially about 100-150℃.
The process progresses smoothly.
又、エピメリ化反応を低級脂肪酸と脂肪族もし
くは芳香族アルデヒドの共存下に実施する場合
は、溶媒中もしくは無溶媒で実施することができ
る。この場合には原料DL−HPG、光学活性
PES、低級脂肪酸、アルデヒド及び要すれば溶媒
を任意の順序で混合しかく拌することによりエピ
メリ化は容易に進行する。該操作は室温乃至溶媒
もしくは低級脂肪酸の還流温度で実施できるがと
りわけ約50〜110℃で実施するのが好ましい。こ
れらいずれの方法を用いる場合においてもDL−
HPG・光学活性PESのうちはじめから存在する
難溶性ジアステレオマーは水中、もしくは低級脂
肪酸中から分別晶出するのでエピメリ化の実施に
際してはこれを一旦採取した後、溶存する易溶性
ジアステレオマーについてエピメリ化を実施して
もよく、或いは難溶性ジアステレオマーを晶出さ
せたまま不均一系で反応を実施してもよい。更に
は適宜エピメリ化反応途中で反応温度を下げ難溶
性ジアステレオマーを採取してもよく、いずれの
場合も反応は容易に進行する。更には所望により
易溶性ジアステレオマーのエピメリ化を低濃度で
実施したのち、適宜冷却して難溶性塩を晶出させ
る如き方法によつて実施してもよい。 Furthermore, when the epimerization reaction is carried out in the coexistence of a lower fatty acid and an aliphatic or aromatic aldehyde, it can be carried out in a solvent or without a solvent. In this case, the raw material DL-HPG, optically active
Epimerization easily proceeds by mixing and stirring PES, lower fatty acids, aldehydes, and, if necessary, a solvent in any order. This operation can be carried out at room temperature or the reflux temperature of the solvent or lower fatty acid, but is preferably carried out at about 50-110°C. When using any of these methods, DL−
The poorly soluble diastereomers that originally exist among HPG and optically active PES are fractionally crystallized from water or lower fatty acids. Epimerization may be carried out, or the reaction may be carried out in a heterogeneous system while the poorly soluble diastereomer is crystallized. Furthermore, the reaction temperature may be lowered as appropriate during the epimerization reaction to collect poorly soluble diastereomers; in either case, the reaction proceeds easily. Furthermore, if desired, epimerization of easily soluble diastereomers may be carried out at a low concentration, followed by appropriate cooling to crystallize poorly soluble salts.
上記目的に用い得る低級脂肪酸としては例えば
ギ酸、酢酸、プロピオン酸、酪酸又は吉草酸の如
き炭素数1〜5の脂肪酸をあげることができ、と
りわけ氷酢酸が入手容易であり好ましい。低級脂
肪酸の濃度は特に限定されないが、通常は約
50W/V%以上、とりわけ約80W/V%以上の濃
度で用いるのが好ましく、また前記DL−HPG・
光学活性PES塩に対し約2〜50倍量用いるのが適
当である。これに対しアルデヒドとしては例えば
ホルムアルデヒド、アセトアルデヒド、プロピオ
ンアルデヒド、n−ブチルアルデヒド、i−ブチ
ルアルデヒド、アクロレインの如き飽和もしくは
不飽和の脂肪族アルデヒド、或いはベンズアルデ
ヒド、サリチルアルデヒド、ヒドロキシベンズア
ルデヒド、ニトロベンズアルデヒド、アニスアル
デヒド、フルフラール等の芳香族アルデヒドを用
いることができ、とりわけサルチルアルデヒド、
n−ブチルアルデヒド等を用いるのが好ましい。
これらのアルデヒドはDL−HPG・光学活性PES
塩に対し0.01〜0.2モル比用いるのが適当であ
る。溶媒を用いて実施する場合、溶媒としては前
記の原料DL−HPG、低級脂肪酸及びアルデヒド
に対し不活性であり、D−HPG・(+)−PES又
はL−HPG・(−)−PESを難溶性塩として析出
させ得るものであればいずれも用いることがで
き、かかる溶媒としては例えば水、ベンゼン、ト
ルエン等をあげることができる。 Examples of lower fatty acids that can be used for the above purpose include fatty acids having 1 to 5 carbon atoms such as formic acid, acetic acid, propionic acid, butyric acid, and valeric acid, and glacial acetic acid is particularly preferred because it is easily available. The concentration of lower fatty acids is not particularly limited, but is usually about
It is preferable to use it at a concentration of 50 W/V% or more, especially about 80 W/V% or more, and the above-mentioned DL-HPG
It is appropriate to use about 2 to 50 times the amount of the optically active PES salt. On the other hand, examples of aldehydes include formaldehyde, acetaldehyde, propionaldehyde, n-butyraldehyde, i-butyraldehyde, saturated or unsaturated aliphatic aldehydes such as acrolein, or benzaldehyde, salicylaldehyde, hydroxybenzaldehyde, nitrobenzaldehyde, anisaldehyde. , aromatic aldehydes such as furfural can be used, especially salicylaldehyde,
It is preferable to use n-butyraldehyde or the like.
These aldehydes are DL-HPG and optically active PES.
It is appropriate to use a molar ratio of 0.01 to 0.2 to the salt. When carrying out using a solvent, the solvent is inert to the above-mentioned raw material DL-HPG, lower fatty acids and aldehydes, and is difficult to use for D-HPG・(+)-PES or L-HPG・(−)-PES. Any solvent can be used as long as it can be precipitated as a soluble salt, and examples of such solvents include water, benzene, and toluene.
更に本発明においては、上記エピメリ化反応を
水の存在下に実施する場合及び脂肪酸、アルデヒ
ドの存在下に実施する場合のいずれの場合にも原
料DL−HPGとともに遊離のアミノ酸を共存させ
ればエピメリ化反応を促進させることができる。
かかるアミノ酸としてはいかなるものでも用いる
ことができ、又、光学活性体であつてもラセミ体
であつてもよく、更にはアミノ酸の混合物であつ
てもよい。しかし一般的にはHPGを用いれば析
出する難溶性塩中に異種アミノ酸が混入しないの
で好ましい。遊離アミノ酸はPESに対して約0.01
〜0.2モル比となるよう用いるのが適当である。 Furthermore, in the present invention, whether the epimerization reaction is carried out in the presence of water or in the presence of fatty acids or aldehydes, if free amino acids are allowed to coexist with the raw material DL-HPG, epimerization can be achieved. oxidation reaction can be promoted.
Any amino acid can be used, and it may be an optically active form, a racemate, or even a mixture of amino acids. However, it is generally preferable to use HPG because it prevents foreign amino acids from being mixed into the hardly soluble salt that is precipitated. Free amino acids are approximately 0.01 to PES
It is appropriate to use it in a molar ratio of ~0.2.
反応終了後晶出する難溶性ジアステレオマーた
るD−HPG・(+)−PES又はL−HPG・(−)−
PESはろ過、遠心分離等の常法により高純度の結
晶として採取することができる。また必要とあれ
ば得られた結晶について洗浄、再結晶等の処理を
することもできる。かくして得られた難溶性ジア
ステレオマー、即ちD−HPG・(+)−PES又は
L−HPG・(−)−PES、は更にアルカリ処理又
はイオン交換樹脂処理の如き常法の脱酸処理をす
ることによつて遊離のD−HPG又はL−HPGを
得ることができる。例えば上記塩の水溶液をアル
カリでHPGの等電点に調整するとD−HPGと
(+)−PES又はL−HPGと(−)−PESとに分離
し、D−又はL−HPGのみが結晶として析出す
る。又、脱酸処理により回収される(+)−又は
(−)−PESは本発明の目的のためにくり返し使用
することができる。 D-HPG・(+)-PES or L-HPG・(-)- which is a poorly soluble diastereomer that crystallizes after the completion of the reaction
PES can be collected as highly pure crystals by conventional methods such as filtration and centrifugation. Further, if necessary, the obtained crystals can be subjected to treatments such as washing and recrystallization. The poorly soluble diastereomer thus obtained, namely D-HPG.(+)-PES or L-HPG.(-)-PES, is further subjected to a conventional deacidification treatment such as alkali treatment or ion exchange resin treatment. Free D-HPG or L-HPG can thereby be obtained. For example, when an aqueous solution of the above salt is adjusted to the isoelectric point of HPG with an alkali, it will separate into D-HPG and (+)-PES or L-HPG and (-)-PES, and only D- or L-HPG will form crystals. Precipitate. Moreover, the (+)- or (-)-PES recovered by deacidification treatment can be used repeatedly for the purpose of the present invention.
以上の如く従来の化学的分割ではDL−HPG100
部から光学活性体HPG50部しか得ることができ
ないが、本発明によればDL−HPGを(−)−PES
又は(+)−PESと反応させ、形成された塩につ
いてその易溶性ジアステレオマーのエピメリ化条
件下で難溶性ジアステレオマー塩の晶析操作を行
なうという簡便な操作でDL−HPGをいずれか一
方の所望の光学活性HPGに実質上全て転換させ
ることができる。従つて、本発明は従来の如く
DL−HPGを他の誘導体に導く必要がなく、また
従来法の如く光学分割工程のあとで改めて不用の
光学活性体のラセミ化を行なう必要がない等、光
学活性PHGの工業的製法として有利な方法とな
るものである。 As mentioned above, in the conventional chemical separation, DL−HPG100
However, according to the present invention, DL-HPG can be obtained from (-)-PES.
Alternatively, DL-HPG can be obtained by a simple procedure of reacting with (+)-PES and crystallizing the poorly soluble diastereomer salt under epimerization conditions of the easily soluble diastereomer of the formed salt. Substantially all of the desired optically active HPG can be converted. Therefore, the present invention is similar to the conventional
This method is advantageous as an industrial production method for optically active PHG, as there is no need to introduce DL-HPG into other derivatives, and there is no need to racemize unnecessary optically active substances after the optical resolution step as in conventional methods. It is a method.
以下、本発明を実施例により更に詳細に説明す
る。 Hereinafter, the present invention will be explained in more detail with reference to Examples.
実施例 1
(1) DL−HPG・塩酸塩10.0gに(+)−PES・ア
ンモニウム塩9.98gを水10ml中で作用させDL
−HPG・(+)−PESの2種ジアステレオマー
を形成せしめこれにDL−HPG0.82gを加えオ
ートクレープ中、140℃で12時間加熱した。反
応終了後(+)−PESの50%水溶液1.82gおよ
び水10mlを加え室温で1時間かく拌した。Example 1 (1) DL-HPG hydrochloride 10.0g was reacted with (+)-PES ammonium salt 9.98g in 10ml water.
Two diastereomers of -HPG/(+)-PES were formed, and 0.82 g of DL-HPG was added thereto and heated in an autoclave at 140°C for 12 hours. After the reaction was completed, 1.82 g of a 50% aqueous solution of (+)-PES and 10 ml of water were added and stirred at room temperature for 1 hour.
析出晶をろ取・乾燥することによりD−
HPG・(+)−PES17.73gを得た。 By filtering and drying the precipitated crystals, D-
17.73 g of HPG.(+)-PES was obtained.
〔α〕25 D−76.5゜(C=1,メタノール)
光学純度97.3%
(2) (1)で得られたD−HPG・(+)−PES14.5gに
メタノール44mlを加えかく拌下に水酸化ナトリ
ウム水溶液を加えてPH6に調整する。室温下に
2時間かく拌しろ過することによりD−
HPG6.5gを得た。 [α] 25 D -76.5° (C=1, methanol) Optical purity 97.3% (2) Add 44 ml of methanol to 14.5 g of D-HPG・(+)-PES obtained in (1) and add water while stirring. Add sodium oxide aqueous solution to adjust the pH to 6. D- by stirring at room temperature for 2 hours and filtering.
Obtained 6.5 g of HPG.
〔α〕25 D−158.0゜(C=1,N−HCl)
光学純度99.8%
実施例 2
DL−HPG11.0g、(−)−PES・アンモニウム
塩12.2g、濃塩酸5.1mlおよび水10mlをオートク
レープ中、120℃で23時間加熱した。ついで反応
混合物に(−)−PESの50%水溶液2.2gおよび水
10mlを加え室温で1時間かく拌した。析出晶をろ
取乾燥することによりL−HPG・(−)−PES20.0
gを得た。 [α] 25 D -158.0゜(C=1,N-HCl) Optical purity 99.8% Example 2 11.0 g of DL-HPG, 12.2 g of (-)-PES ammonium salt, 5.1 ml of concentrated hydrochloric acid and 10 ml of water were added in an auto Heated in a crepe at 120°C for 23 hours. Then, 2.2 g of a 50% aqueous solution of (-)-PES and water were added to the reaction mixture.
10 ml was added and stirred at room temperature for 1 hour. By filtering and drying the precipitated crystals, L-HPG・(-)-PES20.0
I got g.
〔α〕25 D+74.9゜(C=1,メタノール)
光学純度95.6%
実施例 3
実施例1で得たD−HPG・(+)−PES10gに
メタノール30mlを加え約50℃でけん濁しながらア
ンモニア水でPH6に調整し室温で2時間かく拌し
た。析出晶をろ取しD−HPG4.51g〔〔α〕25 D−
157.9゜(C=1,N−HCl)〕を得た後、その母
液を濃縮、乾固し、乾燥して(+)−PES・アン
モニウム塩5.97gを得た。この(+)−PES・ア
ンモニウム塩5.97gに濃硫酸0.8ml、サリチルア
ルデヒド0.3mlおよび氷酢酸70mlを加え100℃でか
く拌しながら、その固液不均一系にDL−
HPG4.74gを徐々に加え同温度で3.5時間かく拌
しサリチルアルデヒド0.3mlを追加した。更に同
温度で3.5時間かく拌した後、減圧下に濃縮して
酢酸を留去する。残査に水10mlを加え室温で1時
間かく拌し析出晶をろ取し、洗浄後乾燥すること
によりD−HPG・(+)−PES7.62gを得る。 [α] 25 D +74.9° (C=1, methanol) Optical purity 95.6% Example 3 Add 30 ml of methanol to 10 g of D-HPG・(+)-PES obtained in Example 1 and suspend at about 50°C. The pH was adjusted to 6 with aqueous ammonia, and the mixture was stirred at room temperature for 2 hours. The precipitated crystals were collected by filtration and 4.51 g of D-HPG [[α]] 25 D −
157.9° (C=1, N-HCl)], the mother liquor was concentrated to dryness and dried to obtain 5.97 g of (+)-PES ammonium salt. Add 0.8 ml of concentrated sulfuric acid, 0.3 ml of salicylaldehyde and 70 ml of glacial acetic acid to 5.97 g of this (+)-PES ammonium salt, and add DL-
4.74 g of HPG was gradually added, stirred at the same temperature for 3.5 hours, and 0.3 ml of salicylaldehyde was added. After further stirring at the same temperature for 3.5 hours, the mixture was concentrated under reduced pressure to remove acetic acid. Add 10 ml of water to the residue, stir at room temperature for 1 hour, filter the precipitated crystals, wash and dry to obtain 7.62 g of D-HPG.(+)-PES.
〔α〕25 D−75.1゜(C=1,メタノール)
光学純度95.7%
実施例 4
DL−HPG16.72gと(+)−PESの50%水溶液
37.24gの混合物に水300mlを加え40〜50℃で3時
間かく拌し、更に室温で2時間かく拌する。析出
したD−HPG・(+)−PES16.74g〔〔α〕25 D−74.
5
゜(C=1,メタノール)光学純度95.0%〕をろ
取する。 [α] 25 D -75.1° (C=1, methanol) Optical purity 95.7% Example 4 50% aqueous solution of DL-HPG16.72g and (+)-PES
Add 300 ml of water to 37.24 g of the mixture, stir at 40-50°C for 3 hours, and further stir at room temperature for 2 hours. Precipitated D-HPG・(+)-PES 16.74 g [[α] 25 D −74.
Five
゜(C=1, methanol) optical purity 95.0%] was collected by filtration.
母液を濃縮乾固し残査を乾燥することによりL
−HPG・(+)−PESを得る。ついでこれに氷酢
酸60mlおよびサルチルアルデヒド0.55mlを加え
100℃で6時間かく拌した。室温まで冷却後、析
出晶をろ取し乾燥することによりD−HPG・
(+)−PES15.9gを得た。 By concentrating the mother liquor to dryness and drying the residue, L
Obtain -HPG・(+)-PES. Next, add 60ml of glacial acetic acid and 0.55ml of salicylaldehyde.
The mixture was stirred at 100°C for 6 hours. After cooling to room temperature, the precipitated crystals are collected by filtration and dried to obtain D-HPG.
15.9 g of (+)-PES was obtained.
〔α〕25 D−74.2゜(C=1,メタノール)
光学純度94.7%
実施例 5
(1) 実施例1(1)と同様にして得たD−HPG・
(+)−PES15gに水15mlを加え、約60℃でけん
濁しながらアンモニア水でPH6に調整する。室
温下で2時間撹拌後、析出晶をろ取し、乾燥し
てD−HPG6.46gを得る。 [α] 25 D -74.2° (C = 1, methanol) Optical purity 94.7% Example 5 (1) D-HPG obtained in the same manner as Example 1 (1)
Add 15 ml of water to 15 g of (+)-PES and adjust the pH to 6 with aqueous ammonia while suspending at approximately 60°C. After stirring at room temperature for 2 hours, the precipitated crystals were collected by filtration and dried to obtain 6.46 g of D-HPG.
〔α〕25 D−158.2゜(C=1、N−HCl)
(2) 母液を濃縮乾固し、残査を乾燥することによ
り(+)−PES・アンモニウム塩9gを得る。
ついでこれに濃塩酸4ml、n−ブチルアルデヒ
ド0.6gおよびプロピオン酸100mlを加え、加熱
しながらDL−HPG7gを徐々に加え100℃で5
時間撹拌し、更にn−ブチルアルデヒド0.6g
を加え同温度で5時間撹拌する。反応液を減圧
下に濃縮してプロピオン酸を留去し、残査を水
15mlを加え、室温下で1時間撹拌後、析出晶を
ろ取し、洗浄、乾燥することによつてD−
HPG・(+)−PES11.5gを得る。 [α] 25 D -158.2° (C=1, N-HCl) (2) The mother liquor was concentrated to dryness and the residue was dried to obtain 9 g of (+)-PES ammonium salt.
Next, 4 ml of concentrated hydrochloric acid, 0.6 g of n-butyraldehyde and 100 ml of propionic acid were added to this, and while heating, 7 g of DL-HPG was gradually added and the mixture was heated at 100°C for 5 minutes.
Stir for an hour and add 0.6 g of n-butyraldehyde.
and stirred at the same temperature for 5 hours. The reaction solution was concentrated under reduced pressure to remove propionic acid, and the residue was dissolved in water.
After adding 15 ml of D-
Obtain 11.5 g of HPG.(+)-PES.
〔α〕25 D−74.8゜(C=1、メタノール)
光学純度95.4%
参考例
(1) 文献〔J.Chem.Soc.,1159(1927)〕記載の
方法に準じ、(±)−α−フエネチルアルコール
500gを常法によりブロム化し、得られる
(±)−α−フエネチルブロミドをスルホン化す
る。得られる反応混合物にD−HPG376g、濃
塩酸620mlおよび水4を加え加熱溶解後20℃
で2時間かく拌する。析出晶をろ取、水洗、乾
燥した後再結晶することにより純粋なD−
HPG・(+)−PES290gを得る。 [α] 25 D -74.8° (C=1, methanol) Optical purity 95.4% Reference example (1) According to the method described in the literature [J.Chem.Soc., 1159 (1927)], (±)-α- phenethyl alcohol
500 g was brominated by a conventional method, and the obtained (±)-α-phenethyl bromide was sulfonated. Add 376 g of D-HPG, 620 ml of concentrated hydrochloric acid, and 4 ml of water to the resulting reaction mixture, dissolve by heating, and then heat to 20°C.
Stir for 2 hours. Pure D- is obtained by filtering the precipitated crystals, washing with water, drying and recrystallizing.
Obtain 290 g of HPG.(+)-PES.
〔α〕25 D−78.9゜(C=1,メタノール)
(2) (1)で得られたD−HPG・(+)−PESをメタ
ノールにけん濁し、水酸化ナトリウム水溶液を
加えてPH6に調整しかく拌する。析出するD−
HPGをろ別し、母液を濃縮してメタノールを
留去する。ついで水を加えてIR−120(H+)イ
オン交換樹脂処理し流出液を濃縮することによ
り(+)−α−フエニルエタンスルホン酸の10
%溶液を得る。 [α] 25 D -78.9° (C = 1, methanol) (2) Suspend the D-HPG・(+)-PES obtained in (1) in methanol, and adjust the pH to 6 by adding an aqueous sodium hydroxide solution. Stir accordingly. D- to precipitate
HPG is filtered off, and the mother liquor is concentrated to remove methanol. Then, by adding water, treating with IR-120 (H + ) ion exchange resin, and concentrating the effluent, 10% of (+)-α-phenylethanesulfonic acid was obtained.
Obtain a % solution.
〔α〕25 D+6.2゜(C=1,水)
(3) (1)においてD−HPGに代えてL−HPGを同
量用いる他は(1)と同様に実施することにより純
粋なL−HPG・(−)−PESを得る。 [α] 25 D +6.2° (C = 1, water) (3) In (1), the same amount of L-HPG is used instead of D-HPG, but pure L-HPG·(-)-PES is obtained.
〔α〕25 D+78.9゜(C=1,メタノール)
(4) (3)で得られたL−HPG・(−)−PESを(2)と
同様に処理することにより(−)−α−フエニ
ルエタンスルホン酸の10%水溶液を得る
〔α〕25 D−6.2゜(C=1,水) [α] 25 D +78.9° (C=1, methanol) (4) By treating L-HPG・(-)-PES obtained in (3) in the same manner as in (2), (-)- Obtain a 10% aqueous solution of α-phenylethanesulfonic acid [α] 25 D -6.2° (C=1, water)
Claims (1)
学活性α−フエニルエタンスルホン酸塩の2種ジ
アステレオマーのうちの易溶性ジアステレオマー
をエピメリ化せしめ、晶出する難溶性ジアステレ
オマーを採取することを特徴とする光学活性P−
ヒドロキシフエニルグリシン・光学活性α−フエ
ニルエタンスルホン酸塩の製法。 2 DL−P−ヒドロキシフエニルグリシン・光
学活性α−フエニルエタンスルホン酸塩の2種ジ
アステレオマーの分別晶析を当該塩の易溶性ジア
ステレオマーのエピメリ化条件下に行ない、晶出
する当該塩の難溶性ジアステレオマーを採取する
特許請求の範囲第1項記載の方法。 3 DL−P−ヒドロキシフエニルグリシン・光
学活性α−フエニルエタンスルホン酸塩の2種ジ
アステレオマーのうち難溶性ジアステレオマーを
分別晶析させた後、溶存する易溶性ジアステレオ
マーをエピメリ化し、更に晶出する難溶性ジアス
テレオマーを採取する特許請求の範囲第1項記載
の方法。 4 エピメリ化反応を水の存在下加熱して行なう
か、または低級脂肪酸と脂肪族もしくは芳香族ア
ルデヒドとの共存下に行なう特許請求の範囲第1
項、第2項又は第3項記載の方法。 5 エピメリ化に際し遊離アミノ酸を共存させる
特許請求の範囲第1項、第2項、第3項又は第4
項記載の方法。 6 水の存在下かつ加熱条件下にDL−P−ヒド
ロキシフエニルグリシン・(+)−α−フエニルエ
タンスルホン酸塩の2種ジアステレオマーの分別
晶析とエピメリ化を行ない、晶出するD−P−ヒ
ドロキシフエニルグリシン・(+)−α−フエニル
エタンスルホン酸塩を採取する特許請求の範囲第
1項、第2項、第3項、第4項又は第5項記載の
方法。[Scope of Claims] 1. A poorly soluble diastereomer of two diastereomers of DL-P-hydroxyphenylglycine/optically active α-phenylethanesulfonate which is epimerized and crystallized. Optically active P- characterized by collecting diastereomers
Method for producing hydroxyphenylglycine/optically active α-phenylethanesulfonate. 2. Perform fractional crystallization of two diastereomers of DL-P-hydroxyphenylglycine optically active α-phenylethanesulfonate under epimerization conditions of the easily soluble diastereomer of the salt, and crystallize. 2. The method according to claim 1, wherein a poorly soluble diastereomer of the salt is collected. 3 After separately crystallizing the poorly soluble diastereomer of the two diastereomers of DL-P-hydroxyphenylglycine/optically active α-phenylethanesulfonate, the dissolved easily soluble diastereomer was epimerized. 2. The method according to claim 1, wherein the poorly soluble diastereomer is collected. 4 Claim 1 in which the epimerization reaction is carried out by heating in the presence of water or in the coexistence of a lower fatty acid and an aliphatic or aromatic aldehyde.
2. The method described in Section 2, Section 2, or Section 3. 5. Claims 1, 2, 3, or 4 in which free amino acids coexist during epimerization.
The method described in section. 6 Perform fractional crystallization and epimerization of two diastereomers of DL-P-hydroxyphenylglycine/(+)-α-phenylethanesulfonate in the presence of water and under heating conditions to crystallize. A method according to claim 1, 2, 3, 4, or 5 for collecting DP-hydroxyphenylglycine (+)-α-phenylethanesulfonate. .
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15004881A JPS5852254A (en) | 1981-09-21 | 1981-09-21 | Preparation of optically active p-hydroxyphenylglycine |
US06/416,338 US4415504A (en) | 1981-09-21 | 1982-09-09 | p-Hydroxyphenylglycine.α-phenylethanesulfonate, process for production thereof and utilization thereof in resolution of p-hydroxyphenylglycine |
EP82108709A EP0075318B1 (en) | 1981-09-21 | 1982-09-21 | P-hydroxyphenylglycine alpha-phenylethanesulfonate, process for production thereof and utilization thereof in resolution of p-hydroxyphenylglycine |
DE8282108709T DE3265433D1 (en) | 1981-09-21 | 1982-09-21 | P-hydroxyphenylglycine alpha-phenylethanesulfonate, process for production thereof and utilization thereof in resolution of p-hydroxyphenylglycine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15004881A JPS5852254A (en) | 1981-09-21 | 1981-09-21 | Preparation of optically active p-hydroxyphenylglycine |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5852254A JPS5852254A (en) | 1983-03-28 |
JPS6261585B2 true JPS6261585B2 (en) | 1987-12-22 |
Family
ID=15488362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15004881A Granted JPS5852254A (en) | 1981-09-21 | 1981-09-21 | Preparation of optically active p-hydroxyphenylglycine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5852254A (en) |
-
1981
- 1981-09-21 JP JP15004881A patent/JPS5852254A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5852254A (en) | 1983-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0007116B1 (en) | Method for resolving racemic 6-methoxy-alpha-methyl-2-naphthalene acetic acid into its enantiomers and resolving medium | |
US4533748A (en) | Process for the optical resolution of the dl-α-hydroxy-3-(4-methoxyphenyl)-3-(2-aminophenylthio)propionic acid | |
US4415504A (en) | p-Hydroxyphenylglycine.α-phenylethanesulfonate, process for production thereof and utilization thereof in resolution of p-hydroxyphenylglycine | |
JPH0312052B2 (en) | ||
US5166426A (en) | Process for producing l-carnitine from d,l-carnitine nitrile salts | |
EP0070114B1 (en) | A process for preparing an optically active p-hydroxyphenyl-glycine or a salt thereof | |
JPS6261585B2 (en) | ||
EP0450684B1 (en) | A process for the preparation of D-(-)-4-hydroxyphenylglycine and L-(+)-4-hydroxyphenylglycine, starting from D.L.-4-hydroxyphenylglycine | |
US5292933A (en) | Process for the resolution of threo-3-[(2-aminophenyl)-thio]-2-hydroxy-3-(4-methoxy-phenyl)propionic acid | |
JPH11228512A (en) | Production of d-alloisoleucine and intermediate therefor | |
JP2971291B2 (en) | Production method of optically active 2-aminobutyric acid | |
JPS6344755B2 (en) | ||
EP0174358A1 (en) | Novel diastereomer salts of phenylalanine and n-acyl derivatives thereof and process for the separation of optically active phenylalanine and n-acyl derivatives thereof | |
EP0251904B1 (en) | Process for the preparation of acidic levomepromazine maleate | |
JPS6261584B2 (en) | ||
JP3888402B2 (en) | Process for producing optically active N-carbobenzoxy-tert-leucine | |
JP3316917B2 (en) | New phenylalanine salt crystals and their production | |
JPH01131143A (en) | Optical resolution of d,l-carnitinenitrile chloride | |
JP3304419B2 (en) | Method for producing optically active 1- (4-halogenophenyl) ethylamine | |
JP2002080459A (en) | Method for producing optically resoluble substance of 2-methylpiperazine | |
JPH07116115B2 (en) | Process for producing optically active aspartic acid β-methyl ester salt | |
JP2007526890A (en) | Method for producing chiral pure N- (trans-4-isopropyl-cyclohexylcarbonyl) -D-phenylalanine and their crystal structure modified products | |
JPH0113462B2 (en) | ||
JPH09143128A (en) | Production of optically active 1-phenylethylamine | |
JPH04266864A (en) | Production of l-dopa |